Last reviewed · How we verify

NCT03986060

Shouldice Hospital Outcome Study

Status unknown Last updated 8 June 2022
What this trial tests

trial in Inguinal Hernia in 3,000 participants. Status unknown.

Timeline
17 June 2019
Primary endpoint
2 May 2023
2 May 2024

Quick facts

Lead sponsorYork University
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment3,000
Start date17 June 2019
Primary completion2 May 2023
Estimated completion2 May 2024
Sites1 location across Canada

Conditions studied

Sponsor

York University

Who can join

Adults 18 to 90, any sex, with Inguinal Hernia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A prospective cohort study recruiting participants from the Shouldice Hospital. The study population consists of healthy patients electing to receive hernia surgery for a primary inguinal hernia on an inpatient basis. The goal of this study is to determine the incidence of hernia pain and its intensity as well as other related outcomes up to one year after primary unilateral inguinal hernia repair.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Matching males and females undergoing Shouldice repair using a prospective, longitudinal design.
    Mainprize M, Svendrovski A, Paasch C, Yilbas A, et al · · 2025 · PMID 40780873 · DOI 10.1503/cjs.012824

Verify or expand the search:

Other recruiting trials for Inguinal Hernia

Currently open trials in the same condition.

Other York University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03986060.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing